A prospective, randomized trial to calculate incidence of Herpes Simplex Virus in an
in-patient burn population and determine efficacy of prophylactic antiviral therapy to
prevent viral infection and/or reactivation. Hypothesis is that antiviral prophylaxis will be
effective in reducing HSV infection/reactivation.